Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Transition products commencing 1 October 2024

NHS England

This public procurement record has 1 release in its history.

Award

17 Oct 2024 at 16:49

Award Notice
Summary of the contracting process

NHS England has completed the award stage for the NHS National Framework for Transition products, set to commence on 1 October 2024. This procurement involves pharmaceutical products, specifically Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection, rivaroxaban tablets, and Imatinib. The framework agreement spans multiple lots with varying durations, ranging from 12 to 20 months, covering extensive regions across the United Kingdom, including the East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, and Yorkshire and the Humber. The total value of the contract is £41,320,000, following an open procurement method.

This tender offers substantial opportunities for business growth, particularly for suppliers within the pharmaceutical industry. Both SMEs and large pharmaceutical companies can benefit from competing in this framework, given the extensive regional coverage and the potential for sustained contracts. Key suppliers involved include Thornton and Ross Ltd, Tillomed Laboratories Ltd, Glenmark Pharmaceuticals Europe Limited, Gilead Sciences Limited, Amarox Limited (an SME), Mercury Pharmaceuticals Limited, Teva UK Limited, Zentiva Pharma UK Ltd, Accord-UK Ltd, Dr. Reddy's Laboratories (UK) Limited (an SME), Celix Pharma Ltd. (an SME), and Seacross Pharmaceuticals Ltd. (an SME). This framework is ideally suited for businesses looking to expand their footprint in the NHS pharmaceutical supply chain.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Transition products commencing 1 October 2024

Notice Description

Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) CM/TNS/24/5712/02 - Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/5ce17d64-f30a-47b5-916f-e45e3f31e0da
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£41,320,000 £10M-£100M
Lots Value
Not specified
Awards Value
£16,224,000 £10M-£100M
Contracts Value
Not specified

Notice Dates

Publication Date
17 Oct 20241 years ago
Submission Deadline
31 Jul 2024Expired
Future Notice Date
Not specified
Award Date
30 Sep 20241 years ago
Contract Period
1 Oct 2024 - 31 May 2026 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN, CHESHIRE
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
12
Supplier Names

Accord-UK Ltd

Amarox Limited

Celix Pharma Ltd.

Dr.Reddy's Laboratories (UK) Limited

Gilead Sciences Limited

Glenmark Pharmaceuticals Europe Limited

Mercury Pharmaceuticals Limited

Seacross Pharmaceuticals Ltd

Teva UK Limited

Thornton and Ross Ltd

Tillomed Laboratories ltd

Zentiva Pharma UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...